Low-dose lipopolysaccharide injection prior to subarachnoid hemorrhage modulates delayed deterioration associated with vasospasm in subarachnoid hemorrhage

Acta Neurochirurgica, Supplementum

Volumn 115, Issue , 2013, Pages 253-258

  Smithason, Saksith ^a   Moore, Shari K ^a   Provencio, J Javier ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Delayed cerebral vasospasm; Inflammation; Lipopolysaccharide; Subarachnoid hemorrhage; Tolerance

Indexed keywords

KERATINOCYTE DERIVED CHEMOKINE; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; CONFERENCE PAPER; CONTROLLED STUDY; DELAYED DETERIORATION ASSOCIATED WITH VASOSPASM; DISEASE EXACERBATION; MALE; MAZE TEST; MOUSE; NONHUMAN; SUBARACHNOID HEMORRHAGE;

EID: 85052608787     PISSN: 00651419     EISSN: 00016268     Source Type: Book Series    
DOI: 10.1007/978-3-7091-1192-5_45     Document Type: Conference Paper

References (19)

1. van Gijn J, Rinkel GJ (2001) Subarachnoid haemorrhage: Diagnosis, causes and management. Brain 124:249-2788
2. Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL (2011) Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis. J Cereb Blood Flow Metab. doi: 10.1038/jcbfm.2011.77
3. Stein SC, Levine JM, Nagpal S, LeRoux PD (2006) Vasospasm as the sole cause of cerebral ischemia: How strong is the evidence Neurosurg Focus 21:E22
4. Vergouwen MD, Ilodigwe D, Macdonald RL (2011) Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 42:924-929. doi: 10.1161/STROKEAHA.110.5979144
5. Provencio JJ, Fu X, Siu A, Rasmussen PA, Hazen SL, Ransohoff RM (2010) CSF neutrophils are implicated in the development of vasospasm in subarachnoid hemorrhage. Neurocrit Care 12:244-251. doi: 10.1007/s12028-009-9308-77
6. Provencio JJ, Altay T, Smithason S, Moore SK, Ransohoff RM (2010) Depletion of Ly6G/C(+) cells ameliorates delayed cerebral vasospasm in subarachnoid hemorrhage. J Neuroimmunol. doi: 10.1016/j.jneuroim.2010.10.0166
7. Pradilla G, Wang PP, Legnani FG, Ogata L, Dietsch GN, Tamargo RJ (2004) Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits. J Neurosurg 101:88-922
8. Zubkov AY, Tibbs RE, Aoki K, Zhang JH (2000) Prevention of vasospasm in penetrating arteries with MAPK inhibitors in dog double-hemorrhage model. Surg Neurol 54:221-227, discussion 227-2288
9. Recinos PF, Pradilla G, Thai Q-A, Perez M, Hdeib AM, Tamargo RJ (2006) Controlled release of lipopolysaccharide in the subarachnoid space of rabbits induces chronic vasospasm in the absence of blood. Surg Neurol 66:463-469, discussion 4699
10. Zhou C, Yamaguchi M, Kusaka G, Schonholz C, Nanda A, Zhang JH (2004) Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 24:419-4311
11. Smithason S, Moore SK, Provencio JJ (2011) Systemic administration of LPS worsens delayed deterioration associated with vasospasm after subarchnoid hemorrhage through a myeloid cell dependent mechanism. Neurocrit Care 16(2):327-334, Epub ahead of print
12. Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP, Stenzel-Poore MP (2004) Endotoxin preconditioning prevents cellular in fl ammatory response during ischemic neuroprotection in mice. Stroke 35:2576-2581. doi: 10.1161/01.STR.0000143450.04438. ae01.STR.0000143450.04438.ae [pii]]
13. Rosenzweig HL, Minami M, Lessov NS, Coste SC, Stevens SL, Henshall DC, Meller R, Simon RP, Stenzel-Poore MP (2007) Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: A novel role for TNFalpha in LPS-ischemic tolerance. J Cereb Blood Flow Metab 27:1663-1674. doi: 10.1038/sj.jcbfm.96004644
14. Tasaki K, Ruetzler CA, Ohtsuki T, Martin D, Nawashiro H, Hallenbeck JM (1997) Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res 748:267-2700
15. Stevens SL, Leung PY, Vartanian KB, Gopalan B, Yang T, Simon RP, Stenzel-Poore MP (2011) Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury. J Neurosci 31: 8456-8463. doi: 10.1523/JNEUROSCI.0821-11. 20111
16. Altay T, Smithason S, Volokh N, Rasmussen PA, Ransohoff RM, Provencio JJ (2009) A novel method for subarachnoid hemorrhage to induce vasospasm in mice. J Neurosci Methods 183:136-140. doi: 10.1016/j.jneumeth.2009.06.0277
17. Marsh B, Stevens SL, Packard AE, Gopalan B, Hunter B, Leung PY, Harrington CA, Stenzel-Poore MP (2009) Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: A critical role for IRF3. J Neurosci 29:9839-9849. doi: 10.1523/JNEUROSCI. 2496-09.20099
18. Broad A, Kirby JA, Jones DE (2007) Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production. Immunology 120:103-111. doi: 10.1111/j.1365-2567. 2006.02485.xx
19. Broad A, Jones DE, Kirby JA (2006) Toll-like receptor (TLR) response tolerance: A key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr Med Chem 13:2487-25022